Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valsartan Plus Hydrochlorothiazide in Patients With Hypertension and Cardiovascular Risk Factors

NCT00171782 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00171782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00171782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valsartan Plus Hydrochlorothiazide in Patients With Hypertension and Cardiovascular Risk Factors
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2004
Completion date
December 31, 2004
Enrollment
76 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension